Dr.Rashmita Kukadia, K12535
Purpose:To Study Efficacy of Difluprednate(0.05%) versus Pred Acetate(1.0%) on Inflammation & IOP after Cataract Surgery. Design:Retrospective study.Methods: study of the clinical outcome of 1000 consecutive patients in prednisolone acetate group versus difluprednate group from January 2016 to December 2016 and January 2017 to December 2017 respectively. No significant difference observed between age, sex and race. Mean IOP did not show significant difference at 1 month postop. At one month postop, 12 eyes in prednisolone group and 49 eyes in difluprednate group had higher IOP higher than 21 mm Hg and 25 eyes with prednisolone group and 70 eyes with difluprednate had postop inflammation. Conclusion: Difluprednate usage shows one distinct advantage of shorter duration of administration but is proven of causing more inflammation and IOP changes compared to prednisolone acetate on postoperative period after cataract surgery.